Coronary disease & ACS

Prevalence and Prognostic Implications of Atherosclerotic Coronary Artery Disease in Type 2 Myocardial Infarction

JACC AdvPublished Observational U.S. cohort study

Main finding · Major adverse cardiovascular outcomesResult — go to the resultAdjusted hazard ratio 1.95 95% CI 1.2–3.6

Authors' conclusion

CAD is common among patients with T2MI and myocardial injury and is associated with poor long-term outcomes. Its presence may facilitate risk-stratification and represent a potential therapeutic target.

Study context

Population
Emergency department patients undergoing high-sensitivity cardiac troponin T measurementT1MI 64 (7.5%) · T2MI 91 (11%) · myocardial injury 703 (82%)
Participants
858 patients
Exposure
Patients with T2MI or myocardial injury and coronary artery disease (CAD) vs type 1 myocardial infarction (MI)
  • T2MI and CADn = 31
  • Myocardial injury and CADn = 245
  • T1MIn = 64reference
Outcome
Major adverse cardiovascular outcomes
Follow-up
Two-year

Main finding

As reported in the abstract

Adjusted hazard ratio

1.95

95% CI 1.2–3.6

By group

T2MI and CADvs T1MI
aHR 1.95 (95% CI 1.2–3.6)

Observational data: associations, not effects.

Further findings

OutcomeT2MI and CADT1MIaHR (95% CI)
All-cause death · Two-yearT2MI and CADvs T1MI52%20%2.2 (1.0–4.5)
Noncardiovascular death · Two-yearT2MI and CADvs T1MI26%5%5.04 (1.3–19.3)
Acute MI · Two-yearT2MI and CADvs T1MI13%2%9.2 (1.01–84.2)
Heart failure hospitalization · Two-yearT2MI and CADvs T1MI32%8%4.6 (1.6–13.7)

Outcomes in myocardial injury and CAD vs T1MI · Two-year

Similar trends, although differences were not statistically significant after adjustment

Original publication

Prevalence and Prognostic Implications of Atherosclerotic Coronary Artery Disease in Type 2 Myocardial Infarction. JACC Adv. Published 19 March 2026. doi:10.1016/j.jacadv.2026.102688

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.